Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Metabotropic glutamate receptor 8 (mGluR8) is a G protein-coupled receptor activated by L-glutamate. It belongs to Group III mGluRs and is primarily Gi/o-coupled, inhibiting cAMP production. Highly expressed in limbic brain regions and the enteric nervous system, mGluR8 acts as a presynaptic autoreceptor, inhibiting glutamate release. It plays roles in learning, memory, anxiety, pain, and gut motility. Dysregulation is implicated in neuropsychiatric disorders, making it a potential therapeutic target.
Gi/o-coupled; inhibits adenylyl cyclase activity, leading to reduced cyclic AMP (cAMP) levels
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Metabotropic Glutamate Receptor 8 (mGluR8).